| The pleiotropic neuroprotective effects of resveratrol in cognitive decline and Alzheimer’s disease pathology: From antioxidant to epigenetic therapy C Grinan-Ferre, A Bellver-Sanchis, V Izquierdo, R Corpas, J Roig-Soriano, ... Ageing research reviews 67, 101271, 2021 | 159 | 2021 |
| Pharmacological inhibition of G9a/GLP restores cognition and reduces oxidative stress, neuroinflammation and β-Amyloid plaques in an early-onset Alzheimer’s disease mouse model C Griñán-Ferré, L Marsal-García, A Bellver-Sanchis, SM Kondengaden, ... Aging (Albany NY) 11 (23), 11591, 2019 | 60 | 2019 |
| A novel NMDA receptor antagonist protects against cognitive decline presented by senescent mice J Companys-Alemany, AL Turcu, A Bellver-Sanchis, MI Loza, JM Brea, ... Pharmaceutics 12 (3), 284, 2020 | 53 | 2020 |
| Cognitive decline and BPSD are concomitant with autophagic and synaptic deficits associated with G9a alterations in aged SAMP8 mice F Vasilopoulou, A Bellver-Sanchis, J Companys-Alemany, J Jarne-Ferrer, ... Cells 11 (16), 2603, 2022 | 15 | 2022 |
| Synergistic Neuroprotective Effects of a Natural Product Mixture against AD Hallmarks and Cognitive Decline in Caenorhabditis elegans and an SAMP8 Mice Model C Griñán-Ferré, A Bellver-Sanchis, M Olivares-Martín, ... Nutrients 13 (7), 2411, 2021 | 13 | 2021 |
| The contribution of epigenetic inheritance processes on age-related cognitive decline and Alzheimer’s disease A Bellver-Sanchis, M Pallàs, C Griñán-Ferré Epigenomes 5 (2), 15, 2021 | 12 | 2021 |
| Identification of the 5-HT1A serotonin receptor as a novel therapeutic target in a C. elegans model of Machado-Joseph disease J Pereira-Sousa, B Ferreira-Lomba, A Bellver-Sanchis, ... Neurobiology of Disease 152, 105278, 2021 | 11 | 2021 |
| G9a inhibition promotes neuroprotection through GMFB regulation in Alzheimer’s disease A Bellver-Sanchis, Q Geng, G Navarro, PA Ávila-López, ... Aging and disease 15 (1), 311, 2024 | 4 | 2024 |
| A Combined Chronic Low-Dose Soluble Epoxide Hydrolase and Acetylcholinesterase Pharmacological Inhibition Promotes Memory Reinstatement in Alzheimer’s Disease Mice Models J Jarne-Ferrer, C Griñán-Ferré, A Bellver-Sanchis, S Vázquez, ... Pharmaceuticals 15 (8), 908, 2022 | 4 | 2022 |
| Structure‐Based Virtual Screening and in vitro and in vivo Analyses Revealed Potent Methyltransferase G9a Inhibitors as Prospective Anti‐Alzheimer's Agents A Bellver‐Sanchis, B Singh Choudhary, J Companys‐Alemany, Sukanya, ... ChemMedChem 17 (13), e202200002, 2022 | 4 | 2022 |
| Neuroprotective effects of G9a inhibition through modulation of peroxisome-proliferator activator receptor gamma-dependent pathways by miR-128 A Bellver-Sanchis, PA Ávila-López, I Tic, D Valle-García, M Ribalta-Vilella, ... Neural Regeneration Research, 10.4103, 0 | 1 | |
| miR-128 通过调节 PPARγ 依赖性通路发挥 G9a 抑制的神经保护作用 A Bellver-Sanchis, PA Ávila-López, I Tic, D Valle-García, M Ribalta-Vilella, ... 中国神经再生研究 (英文版) 19 (11), 2532, 2024 | | 2024 |
| Advancing Personalized Medicine in Neurodegenerative Diseases: The Role of epigenetics and pharmacoepigenomics in Pharmacotherapy C Griñán-Ferré, A Bellver-Sanchis, A Guerrero, M Pallàs Pharmacological Research, 107247, 2024 | | 2024 |
| Nutritional, molecular, and functional properties of a novel enzymatically hydrolyzed porcine plasma product M Solà-Ginés, L Miró, A Bellver-Sanchis, C Griñán-Ferré, M Pallàs, ... Plos one 19 (5), e0301504, 2024 | | 2024 |
| Novel molecular mechanism driving neuroprotection after soluble epoxide hydrolase inhibition: Insights for Alzheimer's disease therapeutics C Griñán‐Ferré, J Jarné‐Ferrer, A Bellver‐Sanchís, S Codony, ... CNS Neuroscience & Therapeutics 30 (4), e14511, 2024 | | 2024 |
| Deletion of Gadd45a Expression in Mice Leads to Cognitive and Synaptic Impairment Associated with Alzheimer’s Disease Hallmarks C Griñán-Ferré, J Jarne-Ferrer, A Bellver-Sanchis, M Ribalta-Vilella, ... International Journal of Molecular Sciences 25 (5), 2595, 2024 | | 2024 |
| Repurposing of Raltitrexed as an Effective G9a/EHMT2 Inhibitor and Promising Anti-Alzheimer’s Agent A Jana, A Bellver-Sanchis, C Griñán-Ferré, DR Banerjee ACS Medicinal Chemistry Letters 14 (11), 1531-1536, 2023 | | 2023 |
| Uncovering the role of G9a modulatory landscape promoting neuronal plasticity and neuroprotection in Alzheimer's disease A Bellver-Sanchis, P Ávila-López, J Companys-Alemany, G Navarro, ... | | 2022 |
| RNA-seq and miRNA-seq data from pharmacological inhibition of the G9a/GLP histone methyltransferase complex with UNC0642 in SAMP8 mice S Pawar, A Bellver-Sanchis, C Griñán-Ferré Data in Brief 36, 107114, 2021 | | 2021 |
| Chromatin modifiers MET-2 and SET-25 are required for behavioural and molecular inheritance after early-life toxic stress in C. elegans C Griñán Ferré, A Bellver-Sanchis, C Hidalgo-Riubal, E Gecse, ... Pòster publicat a: https://ecnp33-ecnp. ipostersessions. com/Default. aspx …, 2020 | | 2020 |
